Skip to content
Research Article Open access CC BY 4.0

LWMH Use in Elderly Patient with Normal Kidney Function Affects Serum Sodium and Potassium Levels: A Case Report

Kim Michael, Wu Leslie, Loi Victor

International Journal of Medical and Pharmaceutical Case Reports · pp. 20–25 · Published 16 Jun 2023

10.9734/ijmpcr/2023/v16i3336

Abstract

An 87-year-old female with a history of paraplegia/neurogenic bladder, chronic left leg wound infection, and recurrent UTI, was admitted with a primary problem of frequent falls and found to have COVID-19 infection. Upon admission, the patient was given enoxaparin for DVT prophylaxis for hypercoagulability due to COVID-19. After 3 days of initiation of enoxaparin, the patient experienced hyponatremia with trending upward levels of potassium. It was believed to be due to the furosemide and was discontinued. Despite furosemide discontinuation, the patient continued down trending of serum sodium and an uptrend of potassium occurred. After 24 hours of discontinued enoxaparin, the sodium and potassium levels plateaued. We believe this patient experienced LMWH-induced hypoaldosteronism.

Enoxaparin hyponatremia LWMH heparin

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.